Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients

被引:129
|
作者
Li, Yu-Yuan [1 ]
Ge, Quan-Xing [1 ]
Cao, Jie [1 ]
Zhou, Yong-Jian [1 ]
Du, Yan-Lei [1 ]
Shen, Bo [1 ]
Wan, Yu-Jui Yvonne [2 ]
Nie, Yu-Qiang [1 ]
机构
[1] Guangzhou Med Univ, Dept Gastroenterol, Guangzhou Peoples Hosp 1, 1 Panfu Rd, Guangzhou 510180, Guangdong, Peoples R China
[2] Univ Calif Davis Hlth Syst, Dept Med Pathol & Lab Med, Sacramento, CA 95817 USA
关键词
Colorectal cancer; Fusobacterium nucleatum; Metastases; Fluorescent quantitative polymerase chain reaction; Fluorescence in situ hybridization; MOLECULAR PATHOLOGICAL EPIDEMIOLOGY; GUT MICROBIOTA; NEOPLASIA; BACTERIA; PATHWAYS; FEATURES; HEALTH; CELLS; HOST;
D O I
10.3748/wjg.v22.i11.3227
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate Fusobacterium nucleatum (F. nucleatum) abundance in colorectal cancer (CRC) tissues and its association with CRC invasiveness in Chinese patients. METHODS: The resected cancer and adjacent normal tissues (10 cm beyond cancer margins) from 101 consecutive patients with CRC were collected. Fluorescent quantitative polymerase chain reaction (FQ-PCR) was applied to detect F. nucleatum in CRC and normal tissues. The difference of F. nucleatum abundance between cancer and normal tissues and the relationship of F. nucleatum abundance with clinical variables were evaluated. Fluorescence in situ hybridization (FISH) analysis was performed on 22 CRC tissues with the highest F. nucleatum abundance by FQ-PCR testing to confirm FQ-PCR results. RESULTS: The median abundance of F. nucleatum in CRC tissues [0.242 (0.178-0.276)] was significantly higher than that in normal controls [0.050 (0.023-0.067)] (P < 0.001). F. nucleatum was over-represented in 88/101 (87.1%) CRC samples. The abundance of F. nucleatum determined by 2-(Delta CT) was significantly greater in tumor samples [0.242 (0.178, 0.276)] than in normal controls [0.050 (0.023, 0.067)] (P < 0.001). The frequency of patients with lymph node metastases was higher in the over-abundance group [52/88 (59.1%)] than in the under-abundance group [0/13 (0%)] (P < 0.005). No significant association of F. nucleatum with other clinico-path-ological variables was observed (P > 0.05). FISH analysis also found more F. nucleatum in CRC than in normal tissues (median number 6, 25th 3, 75th 10 vs 2, 25th 1, 75th 5) (P < 0.01). CONCLUSION: F. nucleatum was enriched in CRC tissues and associated with CRC development and metastasis.
引用
收藏
页码:3227 / 3233
页数:7
相关论文
共 50 条
  • [31] Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism
    Ou, Suwen
    Wang, Hufei
    Tao, Yangbao
    Luo, Kangjia
    Ye, Jinhua
    Ran, Songlin
    Guan, Zilong
    Wang, Yuliuming
    Hu, Hanqing
    Huang, Rui
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [32] Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer
    Wen-dan Chen
    Xin Zhang
    Ya-ping Zhang
    Cong-bo Yue
    Yan-lei Wang
    Hong-wei Pan
    Yan-li Zhang
    Hui Liu
    Yi Zhang
    Current Medical Science, 2022, 42 : 538 - 547
  • [33] Heterogeneous distribution of Fusobacterium nucleatum in the progression of colorectal cancer
    Yamamoto, Shumpei
    Kinugasa, Hideaki
    Hirai, Mami
    Terasawa, Hiroyuki
    Yasutomi, Eriko
    Oka, Shohei
    Ohmori, Masayasu
    Yamasaki, Yasushi
    Inokuchi, Toshihiro
    Harada, Keita
    Hiraoka, Sakiko
    Nouso, Kazuhiro
    Tanaka, Takehiro
    Teraishi, Fuminori
    Fujiwara, Toshiyoshi
    Okada, Hiroyuki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (07) : 1869 - 1876
  • [34] A New Comorbidity in Periodontitis: Fusobacterium nucleatum and Colorectal Cancer
    Mesa, Francisco
    Mesa-Lopez, Maria Jose
    Egea-Valenzuela, Juan
    Benavides-Reyes, Cristina
    Nibali, Luigi
    Ide, Mark
    Mainas, Giuseppe
    Rizzo, Manfredi
    Magan-Fernandez, Antonio
    MEDICINA-LITHUANIA, 2022, 58 (04):
  • [35] Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study
    Ilozumba, Mmadili N.
    Lin, Tengda
    Hardikar, Sheetal
    Byrd, Doratha A.
    Round, June L.
    Stephens, W. Zac
    Holowatyj, Andreana N.
    Warby, Christy A.
    Damerell, Victoria
    Li, Christopher I.
    Figueiredo, Jane C.
    Toriola, Adetunji T.
    Shibata, David
    Fillmore, Gary C.
    Pickron, Bartley
    Siegel, Erin M.
    Kahlert, Christoph
    Florou, Vaia
    Gigic, Biljana
    Ose, Jennifer
    Ulrich, Cornelia M.
    CANCER MEDICINE, 2024, 13 (22):
  • [36] Circulating Bacterial DNA in Colorectal Cancer Patients: The Potential Role of Fusobacterium nucleatum
    Koliarakis, Ioannis
    Lagkouvardos, Ilias
    Vogiatzoglou, Konstantinos
    Tsamandouras, Ioannis
    Intze, Evangelia
    Messaritakis, Ippokratis
    Souglakos, John
    Tsiaoussis, John
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (16)
  • [37] Fusobacterium nucleatum infection is correlated with tumor metastasis and postoperative survival of colorectal cancer patients in China
    Sun, Yuan
    An, Qi-Ming
    Tian, Xiu-Yun
    Wang, Zi-Lei
    Guan, Xiao-Ya
    Dong, Bin
    Zhao, Min
    Hao, Chun-Yi
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (05) : 579 - 588
  • [38] Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice
    Wang, Maijian
    Li, Yong
    Yang, Xuefeng
    Liu, Zhenxing
    Wang, Kai
    Gong, Dengmei
    Li, Jida
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (11)
  • [39] Fusobacterium nucleatum and cancer
    Alon-Maimon, Tamar
    Mandelboim, Ofer
    Bachrach, Gilad
    PERIODONTOLOGY 2000, 2022, 89 (01) : 166 - 180
  • [40] Salivary Fusobacterium nucleatum serves as a potential biomarker for colorectal cancer
    Zhang, Xin
    Zhang, Yaping
    Gui, Xinru
    Zhang, Yanli
    Zhang, Zhenhong
    Chen, Wendan
    Zhang, Xiaowei
    Wang, Yanxiang
    Zhang, Mengjiao
    Shang, Ziqi
    Xin, Yiwei
    Zhang, Yi
    ISCIENCE, 2022, 25 (05)